“We are feeling increasing political pressure in Europe [regarding] the sponsorship of delegates at medical meetings and we are expecting that the system will change dramatically in the future. So we all have to be prepared for the worst.” That was the warning from Anna Frick, conference and exhibition team director, global marketing, AstraZeneca, Mölndal, Sweden; and president, International Pharmaceutical Congress Advisory Association, Basel, Switzerland. (In Europe, unlike the U.S., it's ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Global Pharma Crackdown, you'll get exclusive access to a large archive of premium content.

Already registered? here.